Cetera Investment Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.1M Buy
66,807
+989
+2% +$401K 0.05% 412
2025
Q1
$32.8M Buy
65,818
+7,703
+13% +$3.83M 0.06% 314
2024
Q4
$30.2M Sell
58,115
-2,078
-3% -$1.08M 0.06% 309
2024
Q3
$37.2M Buy
60,193
+3,408
+6% +$2.11M 0.08% 244
2024
Q2
$31.4M Sell
56,785
-129
-0.2% -$71.3K 0.07% 266
2024
Q1
$33.1M Buy
56,914
+40,460
+246% +$23.5M 0.08% 258
2023
Q4
$8.73M Sell
16,454
-945
-5% -$502K 0.07% 256
2023
Q3
$8.81M Sell
17,399
-1,534
-8% -$776K 0.08% 255
2023
Q2
$9.88M Sell
18,933
-766
-4% -$400K 0.08% 226
2023
Q1
$11.4M Sell
19,699
-1,427
-7% -$822K 0.1% 193
2022
Q4
$11.6M Buy
21,126
+8,937
+73% +$4.92M 0.11% 183
2022
Q3
$6.18M Sell
12,189
-2,325
-16% -$1.18M 0.12% 174
2022
Q2
$7.89M Buy
14,514
+578
+4% +$314K 0.13% 167
2022
Q1
$8.23M Buy
13,936
+598
+4% +$353K 0.12% 182
2021
Q4
$8.9M Sell
13,338
-1,051
-7% -$701K 0.13% 172
2021
Q3
$8.22M Buy
14,389
+1,980
+16% +$1.13M 0.13% 172
2021
Q2
$6.26M Buy
12,409
+2,059
+20% +$1.04M 0.1% 220
2021
Q1
$4.72M Sell
10,350
-1,628
-14% -$743K 0.09% 236
2020
Q4
$5.58M Buy
11,978
+8,588
+253% +$4M 0.11% 200
2020
Q3
$1.5M Sell
3,390
-292
-8% -$129K 0.12% 194
2020
Q2
$1.33M Buy
3,682
+96
+3% +$34.8K 0.12% 193
2020
Q1
$1.02M Buy
3,586
+63
+2% +$17.9K 0.12% 191
2019
Q4
$1.14M Buy
3,523
+187
+6% +$60.6K 0.11% 190
2019
Q3
$972K Buy
3,336
+469
+16% +$137K 0.12% 192
2019
Q2
$847K Sell
2,867
-31
-1% -$9.16K 0.11% 203
2019
Q1
$793K Buy
2,898
+67
+2% +$18.3K 0.11% 199
2018
Q4
$632K Sell
2,831
-438
-13% -$97.8K 0.1% 208
2018
Q3
$794K Buy
3,269
+835
+34% +$203K 0.11% 193
2018
Q2
$503K Buy
2,434
+357
+17% +$73.8K 0.09% 240
2018
Q1
$429K Buy
+2,077
New +$429K 0.08% 248